Hackensack University Medical Center
Anemia in zidovudine-treated HIV-infected patients. Starting dose is 100 U/kg IV or SQ TIW for 8 weeks. Treatment is for patients with endogenous serum erythropoeitin level is ≤ 500 mUnits/ml who are receiving a dose of zidovudine ≤ 4200mg/week. Anemia in cancer patients on chemotherapy. Starting dose is 150 U/kg SQ TIW. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- aapro m extermann m repetto l
- pharmacology—chemotherapy and supportive care
- possible side effects of docetaxel national cancer institute
- registration status pharmaceutical benefits scheme pbs
- cancer outline buffalo academy of veterinary medicine
- hackensack university medical center
- cmn erythropoiesis stimulating agents
Related searches
- hackensack university medical center jobs
- hackensack university medical center intr
- hackensack university medical center dire
- hackensack university medical center map
- hackensack university medical center billing
- hackensack university medical center email
- hackensack university medical center my chart
- hackensack university medical center directory
- hackensack university medical center records
- hackensack university medical center nj
- hackensack university medical center hackensack nj
- hackensack university medical center medical records